Gates-backed vaccine slashes African meningitis deaths

A Gates Foundation-funded vaccine has helped Africa have its least severe meningitis season in a decade. In the first 5 months of 2013, 857 deaths were reported in countries under enhanced surveillance. One nonprofit said meningitis killed more than 5,000 people in sub-Saharan Africa in 2009. News

Suggested Articles

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.

GSK's Shingrix has nabbed a huge chunk of the U.S. shingles-shot market, just five months after it was approved by the FDA.